Abstract
Phosphatidylinositol 3-kinase (PI3K) and serine/threonine protein kinase B (PKB or Akt) pathways regulate important cellular processes and are related to a number of human pathologies, such as cancer. The development of kinase inhibitors, with particular attention to small molecule analogues of natural phosphoinositides for pathway interruption and therapeutic applications will be reviewed.
Keywords: Kinases, Akt, PI3K, cancer, kinase inhibitors, allosteric inhibitors, phosphatidylinositol, phosphatidylinositol analogues
Mini-Reviews in Medicinal Chemistry
Title: Synthesis and Biological Activity of Akt/PI3K Inhibitors
Volume: 6 Issue: 10
Author(s): C. Redaelli, F. Granucci, L. De Gioia and L. Cipolla
Affiliation:
Keywords: Kinases, Akt, PI3K, cancer, kinase inhibitors, allosteric inhibitors, phosphatidylinositol, phosphatidylinositol analogues
Abstract: Phosphatidylinositol 3-kinase (PI3K) and serine/threonine protein kinase B (PKB or Akt) pathways regulate important cellular processes and are related to a number of human pathologies, such as cancer. The development of kinase inhibitors, with particular attention to small molecule analogues of natural phosphoinositides for pathway interruption and therapeutic applications will be reviewed.
Export Options
About this article
Cite this article as:
Redaelli C., Granucci F., De Gioia L. and Cipolla L., Synthesis and Biological Activity of Akt/PI3K Inhibitors, Mini-Reviews in Medicinal Chemistry 2006; 6 (10) . https://dx.doi.org/10.2174/138955706778560139
DOI https://dx.doi.org/10.2174/138955706778560139 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Interplay between Epigenetics & Cancer Metabolism
Current Pharmaceutical Design Pharmaceutical Production of Anti-tumor and Immune-potentiating Enterococcus faecalis-2001 β-glucans: Enhanced Activity of Macrophage and Lymphocytes in Tumor-implanted Mice
Current Pharmaceutical Biotechnology Cosignaling Molecules Around LIGHT-HVEM-BTLA: From Immune Activation to Therapeutic Targeting
Current Molecular Medicine Novel Compounds from Marine Microorganisms that Inhibit Mammalian DNA Polymerase
Current Organic Chemistry Subject Index to Volume 4
Current Medicinal Chemistry - Anti-Cancer Agents RNA Interference and Potential Applications
Current Topics in Medicinal Chemistry Base Excision Repair: Contribution to Tumorigenesis and Target in Anticancer Treatment Paradigms
Current Medicinal Chemistry Data Science Approaches to Pharmacogenetics
Current Molecular Medicine Defensins: Key Molecules in Ocular Surface Protection
Current Immunology Reviews (Discontinued) Histone Deacetylases: Anti-Angiogenic Targets in Cancer Therapy
Current Cancer Drug Targets The Role of miR-124 in Drosophila Alzheimer's Disease Model by Targeting Delta in Notch Signaling Pathway
Current Molecular Medicine Bone Effects of Glitazones and Other Anti-Diabetic Drugs
Current Drug Safety Chromogranin A and the Endothelial Barrier Function
Current Medicinal Chemistry Green Tea Catechins as Novel Antitumor and Antiangiogenic Compounds
Current Medicinal Chemistry - Anti-Cancer Agents Evaluation of <sup>177</sup>Lu-EDTMP in Dogs with Spontaneous Tumor Involving Bone: Pharmacokinetics, Dosimetry and Therapeutic Efficacy
Current Radiopharmaceuticals The Role of CXCR3 in Neurological Diseases
Current Neuropharmacology Recent Progress in the Development of Selective TRPV1 Antagonists for Pain
Current Topics in Medicinal Chemistry TRP Channels and Pain
Current Pharmaceutical Design Dexamethasone Reduces Cell Adhesion and Migration of T47D Breast Cancer Cell Line
Anti-Cancer Agents in Medicinal Chemistry Anticoagulant and Fibrinolytic Drugs – Possible Agents in Treatment of Lung Cancer?
Anti-Cancer Agents in Medicinal Chemistry